To view this email as a web page, click here.
 
DRUG APPROVALS
 
Hep C drug approved for kids
FDA approved supplemental applications for 2 primary hepatitis C medications to be used in children for the first time.
Read more
 
Novel drug approved for Huntington's symptom
FDA recently approved deutetrabenazine (Austedo) to treat this movement disorder associated with Huntington's disease (HD). The medication is only the second product approved to treat HD.
Read more
 
Drug prolongs IPF life expectancy: Study
Two recent studies show that pirfenidone (Esbriet) prolongs life expectancy by 2.47 years for IPF patients and that Esbriet and nintedanib (Ofev) reduce IPF patients' decline in lung function.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.